Amendment and Mail Process Complete

DXEVO

LARKEN LABORATORIES, INC.

Amendment and Mail Process Complete

Trademark Snap Shot Amendment & Mail Processing Stylesheet
(Table presents the data on Amendment & Mail Processing Complete)

OVERVIEW

SERIAL NUMBER 88334412 FILING DATE 03/11/2019
REG NUMBER 0000000 REG DATE N/A
REGISTER PRINCIPAL MARK TYPE TRADEMARK
INTL REG # N/A INTL REG DATE N/A
TM ATTORNEY ROSEN, AMANDA ROBYN
L.O. ASSIGNED N30-NOT FOUND

PUB INFORMATION

RUN DATE 01/14/2020
PUB DATE N/A
STATUS 616-REVIVE-AWAITING FURTHER ACTION
STATUS DATE 12/16/2019
LITERAL MARK ELEMENT DXEVO

DATE ABANDONED N/A DATE CANCELLED N/A
SECTION 2F NO SECTION 2F IN PART NO
SECTION 8 NO SECTION 8 IN PART NO
SECTION 15 NO REPUB 12C N/A
RENEWAL FILED NO RENEWAL DATE N/A
DATE AMEND REG N/A


FILING BASIS

FILED BASIS CURRENT BASIS AMENDED BASIS
1 (a) NO 1 (a) NO 1 (a) NO
1 (b) YES 1 (b) YES 1 (b) NO
44D NO 44D NO 44D NO
44E NO 44E NO 44E NO
66A NO 66A NO

NO BASIS NO NO BASIS NO


MARK DATA

STANDARD CHARACTER MARK YES
LITERAL MARK ELEMENT DXEVO
MARK DRAWING CODE 4-STANDARD CHARACTER MARK
COLOR DRAWING FLAG NO

CURRENT OWNER INFORMATION

PARTY TYPE 10-ORIGINAL APPLICANT
NAME LARKEN LABORATORIES, INC.
ADDRESS 276 Nissan Parkway, Bldg. A, Suite 200
Canton, MS 39046
ENTITY 03-CORPORATION
CITIZENSHIP Mississippi

GOODS AND SERVICES

INTERNATIONAL CLASS 010
          DESCRIPTION TEXT Pharmaceutical preparations for treating inflammation of the skin, joints, lungs, and other organs
INTERNATIONAL CLASS 044
          DESCRIPTION TEXT Medical services, namely, medical treatment for inflammation of the skin, joints, lungs, and other organs

GOODS AND SERVICES CLASSIFICATION

INTERNATIONAL CLASS 010 FIRST USE DATE NONE FIRST USE IN COMMERCE DATE NONE CLASS STATUS 6-ACTIVE
INTERNATIONAL CLASS 044 FIRST USE DATE NONE FIRST USE IN COMMERCE DATE NONE CLASS STATUS 6-ACTIVE

MISCELLANEOUS INFORMATION/STATEMENTS

CHANGE IN REGISTRATION NO

PROSECUTION HISTORY

DATE ENT CD ENT TYPE DESCRIPTION ENT NUM
01/13/2020 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED 017
01/13/2020 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE 016
01/06/2020 ALIE A ASSIGNED TO LIE 015
12/16/2019 NREV E NOTICE OF REVIVAL - E-MAILED 014
12/16/2019 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED 013
12/16/2019 PETG O PETITION TO REVIVE-GRANTED 012
12/16/2019 PROA I TEAS PETITION TO REVIVE RECEIVED 011
12/02/2019 MAB2 E ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND 010
12/02/2019 ABN2 O ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE 009
05/20/2019 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED 008
05/20/2019 GNRT O NON-FINAL ACTION E-MAILED 007
05/20/2019 CNRT R NON-FINAL ACTION WRITTEN 006
05/20/2019 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED 005
05/20/2019 GNRT F NON-FINAL ACTION E-MAILED 004
05/20/2019 CNRT R NON-FINAL ACTION WRITTEN 003
05/20/2019 DOCK D ASSIGNED TO EXAMINER 002
03/28/2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM 001

CURRENT CORRESPONDENCE INFORMATION

ATTORNEY Austin Bonderer
CORRESPONDENCE ADDRESS Austin Bonderer
THE LAW OFFICE OF AUSTIN BONDERER, PC
LARKEN-03T
250 W SANTA FE AVE UNIT 550
FULLERTON CA 92832
DOMESTIC REPRESENTATIVE NONE

Amendment and Mail Process Complete [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed